Supply Chain

Few areas of the EU Medical Device Regulation (MDR 2017/745) cause as much anxiety as clinical evaluation. Once a tick-box dossier exercise under the old MDD, it is now a continuous, evidence-driven process scrutinised by Notified Bodies and regulators alike.
As the European MDR and the US FDA’s new Quality Management System Regulation (QMSR) converge, scrutiny has intensified. Every audit now tests whether a company’s medical-device quality management system (QMS) truly works or merely exists on paper.

Risk and quality are two sides of the same compliance coin. Yet in many medical-device companies, they still live in separate silos – quality managers guard procedures while engineers manage risk files in isolation. That gap can be costly. It’s where design failures hide, where corrective actions repeat, and where auditors find the most painful non-conformities.
As the European MDR and the US FDA’s new Quality Management System Regulation (QMSR) converge, scrutiny has intensified. Every audit now tests whether a company’s medical-device quality management system (QMS) truly works or merely exists on paper.

While both standards share the same DNA, they serve very different purposes. ISO 9001 is the universal language of quality management; ISO 13485 is its medical-device-specific dialect – one that speaks directly to regulators, auditors, and patients.
As the European MDR and the US FDA’s new Quality Management System Regulation (QMSR) converge, scrutiny has intensified. Every audit now tests whether a company’s medical-device quality management system (QMS) truly works or merely exists on paper.

In today’s medical-device sector, ISO 13485 compliance is no longer optional – it’s the ticket to market access, regulatory trust, and operational maturity.
As the European MDR and the US FDA’s new Quality Management System Regulation (QMSR) converge, scrutiny has intensified. Every audit now tests whether a company’s medical-device quality management system (QMS) truly works or merely exists on paper.